|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$37.73 |
$38.69 |
$37.73 |
$38.64 |
1.26M | 04/22/2024 |
$38.82 |
$39.05 |
$38.28 |
$38.71 |
525.20K | 04/23/2024 |
$38.75 |
$39.42 |
$38.70 |
$38.97 |
557.90K | 04/24/2024 |
$38.98 |
$39.70 |
$38.82 |
$39.12 |
620.50K | 04/25/2024 |
$38.71 |
$38.75 |
$38.23 |
$38.46 |
693.30K |
|
Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® drug delivery technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. | |
|
Halozyme Therapeutics (HALO) has the following price history information. Looking back at HALO historical stock prices for the last five trading days, on April 19, 2024, HALO opened at $37.73, traded as high as $38.69 and as low as $37.73, and closed at $38.64. Trading volume was a total of 1.26M shares. On April 22, 2024, HALO opened at $38.82, traded as high as $39.05 and as low as $38.28, and closed at $38.71. Trading volume was a total of 525.20K shares. On April 23, 2024, HALO opened at $38.75, traded as high as $39.42 and as low as $38.70, and closed at $38.97. Trading volume was a total of 557.90K shares. On April 24, 2024, HALO opened at $38.98, traded as high as $39.70 and as low as $38.82, and closed at $39.12. Trading volume was a total of 620.50K shares. On April 25, 2024, HALO opened at $38.71, traded as high as $38.75 and as low as $38.23, and closed at $38.46. Trading volume was a total of 693.30K shares.
HALO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Halozyme Therapeutics shares, starting with a $10,000 purchase of HALO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$7.41 |
|
End price/share: |
$38.46 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
419.03% |
|
Average Annual Total Return: |
17.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$51,917.09 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $38.64 | 04/22/2024 | $38.71 | 04/23/2024 | $38.97 | 04/24/2024 | $39.12 | 04/25/2024 | $38.46 |
|
|